Did the company provide guidance for the rest of 2025, and what could that mean for the stock valuation? | CURV (Sep 04, 2025) | Candlesense

Did the company provide guidance for the rest of 2025, and what could that mean for the stock valuation?

Guidance – none was issued

The press release only notes that Q2 2025 sales and Adjusted EBITDA met the Company’s internal expectations. There is no forward‑looking guidance for the remainder of 2025 (i.e., no revenue, EBITDA, or earnings‑per‑share outlook for the second half or full‑year).

What that means for valuation

* Valuation is now stuck to “run‑rate” fundamentals. With no guidance, investors must price the stock based on the most recent quarter’s performance and any historic growth trends. The market will likely lean on the Q2 adjusted‑EBITDA margin and the “in‑line with expectations” comment to extrapolate FY 2025 earnings, but this adds a layer of subjectivity and widens the valuation range.

* Higher price‑to‑earnings (P/E) risk. If analysts have been assigning a forward‑P/E based on an assumed FY 2025 EPS that is not anchored by official guidance, the stock may be priced on optimistic earnings assumptions. Should the Company’s second‑half results fall short of those extrapolations, the valuation could be compressed sharply.

* Increased upside if guidance comes out bullish. The absence of guidance leaves room for a “beat‑and‑talk” catalyst. Historically, when a company that previously omitted guidance releases a hopeful outlook, the stock can rally 5‑10 % on the upside.

Trading implications

Scenario Likely price action
Maintain status‑quo (no new guidance, Q2 consistent) The stock should trade near its current valuation, with the market holding the “in‑line” narrative. Expect modest upside/downside limited to 2‑3 % as investors price‑in historical growth patterns.
Negative surprises in upcoming Q3/Q4 (e.g., margin compression) Without a guidance cushion, any downside deviation will be met with a quick re‑rating of the forward multiples, potentially triggering a 5‑8 % pull‑back.
Positive forward‑looking guidance (e.g., higher‑than‑forecast sales/EBITDA) A bullish outlook would likely spark a short‑cover rally and a 5‑10 % jump as the market upgrades earnings expectations and compresses the P/E multiple.

Actionable take‑away

Given the current lack of guidance, the stock is largely priced on the “in‑line” Q2 performance and historical growth trends. If you’re already long and the price is reflecting a relatively modest forward P/E (≈ 15‑18× 2025‑adjusted EBITDA based on Q2 run‑rate), hold while keeping a tight stop just above the recent swing‑high to protect against an unexpected downward revision. Conversely, if you’re watching on the sidelines, a forthcoming optimistic FY 2025 outlook could be a catalyst for a short‑cover rally—position a modest long with a target of +7 % and a stop about 4 % below the entry level.